TY - JOUR AU - Löwenberg, B. PY - 2001 DA - 2001// TI - Prognostic factors in acute myeloid leukaemia JO - Best Pract Res ClinHaematol. VL - 14 UR - https://doi.org/10.1053/beha.2000.0116 DO - 10.1053/beha.2000.0116 ID - Löwenberg2001 ER - TY - JOUR AU - Pleyer, L. AU - Stauder, R. AU - Burgstaller, S. AU - Schreder, M. AU - Tinchon, C. AU - Pfeilstocker, M. PY - 2013 DA - 2013// TI - Azacitidine in patients with WHO-defined AML—results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group JO - J HematolOncol. VL - 6 ID - Pleyer2013 ER - TY - JOUR AU - Helm, L. H. AU - Scheepers, E. R. AU - Veeger, N. J. AU - Daenen, S. M. AU - Mulder, A. B. AU - Berg, E. PY - 2013 DA - 2013// TI - Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients JO - J Hematol Oncol. VL - 6 UR - https://doi.org/10.1186/1756-8722-6-29 DO - 10.1186/1756-8722-6-29 ID - Helm2013 ER - TY - STD TI - Shi L, Chen S, Zha X, Xu Y, Xu L, Yang L, et al. Enhancement of the TCRζ expression, polyclonal expansion and activation of T cells from patients with AML after IL-2, IL-7 and IL-12 induction. DNA Cell Biol. 2015 Mar 10. [Epub ahead of print] ID - ref4 ER - TY - JOUR AU - Li, Y. PY - 2008 DA - 2008// TI - Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases JO - Hematology. VL - 13 UR - https://doi.org/10.1179/102453308X343482 DO - 10.1179/102453308X343482 ID - Li2008 ER - TY - JOUR AU - Chen, X. AU - Woiciechowsky, A. AU - Raffegerst, S. AU - Schendel, D. AU - Kolb, H. J. AU - Roskrow, M. PY - 2000 DA - 2000// TI - Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis JO - Br J Haematol. VL - 111 ID - Chen2000 ER - TY - JOUR AU - Chen, S. AU - Yang, L. AU - Chen, S. AU - Li, Y. PY - 2009 DA - 2009// TI - TCR ζ chain expression in T cells from patients with CML JO - Hematology. VL - 14 UR - https://doi.org/10.1179/102453309X385241 DO - 10.1179/102453309X385241 ID - Chen2009 ER - TY - JOUR AU - Huang, L. AU - Chen, S. AU - Zha, X. AU - Yang, L. AU - Li, B. AU - Yu, Z. PY - 2012 DA - 2012// TI - Expression feature of CD3, FcεRIγ and Zap-70 in patients with chronic lymphocytic leukemia JO - Hematology. VL - 17 UR - https://doi.org/10.1179/102453312X13221316477895 DO - 10.1179/102453312X13221316477895 ID - Huang2012 ER - TY - JOUR AU - Zha, X. AU - Chen, S. AU - Yang, L. AU - Shi, L. AU - Li, B. AU - Wu, X. PY - 2012 DA - 2012// TI - Up-regulated TCRζ enhances interleukin-2 production in T-cells from patients with CML JO - DNA Cell Biol. VL - 31 UR - https://doi.org/10.1089/dna.2012.1798 DO - 10.1089/dna.2012.1798 ID - Zha2012 ER - TY - JOUR AU - Nambiar, M. P. AU - Fisher, C. U. AU - Warke, V. G. AU - Krishnan, S. AU - Mitchell, J. P. AU - Delaney, N. PY - 2003 DA - 2003// TI - Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus JO - Arthritis Rheum. VL - 48 UR - https://doi.org/10.1002/art.11072 DO - 10.1002/art.11072 ID - Nambiar2003 ER - TY - JOUR AU - Kaufman, H. L. AU - Ruby, C. E. AU - Hughes, T. AU - Slingluff, C. L. PY - 2014 DA - 2014// TI - Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma JO - J Immunother Cancer. VL - 2 UR - https://doi.org/10.1186/2051-1426-2-11 DO - 10.1186/2051-1426-2-11 ID - Kaufman2014 ER - TY - JOUR AU - Xuan, L. AU - Wu, X. AU - Zhang, Y. AU - Fan, Z. AU - Ling, Y. AU - Huang, F. PY - 2011 DA - 2011// TI - Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease JO - J Transl Med. VL - 9 UR - https://doi.org/10.1186/1479-5876-9-215 DO - 10.1186/1479-5876-9-215 ID - Xuan2011 ER -